Hipertensión Pulmonar del Grupo 3, Asociada a EPOC y EPID

26 March 2026

This webinar is part of the Latin America Task Force series and focuses on Group 3 pulmonary hypertension (PH) associated with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD).

The session was delivered in Spanish and brings together international experts to explore the impact of the updated haemodynamic definition of PH (mPAP >20 mmHg, PVR >2), which has led to increased detection in COPD, ILD, and mixed phenotypes such as CPFE. The recording covers diagnosis, interpretation of investigations, and current treatment approaches, alongside expert-led case discussions.

This PVRI webinar was hosted live on 18 March 2026, 15:00 GMT.

Share: